Summary Initial classifications of 1009 testicular tumours were reviewed as part of a population based survey of all testicular neoplasms in Victoria, Australia, between 1950 and 1978. All reviews were made by one of two pathologists at the Peter MacCallum Cancer Institute, using the system of the British Testicular Tumour Panel. Accuracy of diagnosis varied markedly over the time period and with pathological category. Seven cases were initially designated malignancies but were determined to be non-malignant conditions upon review. In each decade, review reduced the proportion of seminomas and increased the proportion of non-seminoma germ cell tumours (NSGCT) and non germ cell tumours. Reclassification resulted in changed age specific incidences of seminoma and NSGCT, most noticeably in 1950-59. Trends in age standardised incidence of seminoma and NSGCT were not affected by reclassification although the values were. The trend in age standardised incidence of non germ cell tumours was affected by reclassification. The implications of the changes in classification for epidemiological studies and clinical management are discussed.
Accurate assignment of a malignancy to the correct pathological category is essential both for treatment of the patient and for scientific investigation of aetiology. In the case of testis cancer, germ cell tumours are distinct in terms of aetiology, behaviour and therapy from other malignancies primary in the testis such as lymphoma, sarcomas and tumours of the gonadal stroma. The major histological breakdown of germ cell tumours is seminoma and nonseminoma (NSGCT). The two categories have distinct age distributions, with NSGCTs concentrated in the age group 15-30 and seminomas about 10 years older (Senturia, 1987) . The possibility of different initiating or promoting factors for the two groups makes it desirable that analyses investigating aetiology reliably distinguish between them. Treatment policy also differs markedly between broad groups.
The incidence of germ cell tumours has been increasing internationally (Forman, 1989) and in Australia (Stone et al., 1991a) while the rate of occurrence of other testicular malignancies has remained largely unchanged. In the field of testis cancer epidemiology, attention is currently focussed on the identification of aetiological factors underlying the large increase in incidence, which has even been called an epidemic (Brown et al., 1987) .
A common source of cases for epidemiological studies is cancer registry data, whose diagnoses are determined by pathologists with varying experience. That diagnoses from such mixed sources are not always reliable or consistent has been shown for thyroid cancer (Saxen et al., 1975) and lymphatic neoplasms (Dougan et al., 1981) . In both these studies, diagnostic review of cancer registry material led to substantial reclassifications. Unreliable diagnosis is particularly likely to occur when the tumour is rare and there is no general agreement on classification systems. Such is the case with neoplasms of the testis.
Although some epidemiological studies of testis cancer incorporate review of the pathology of the case material, the only detailed study of the revisions following such review is that of Teppo (1973) who examined testis cancers from the Finnish Cancer Registry. He concluded that primary diagnoses of histological sub groups could not be relied upon.
As part of a population based survey of the epidemiology of testis cancer in the state of Victoria, Australia, we reviewed all available histological material. We present here the results of the review of the pathology of the tumours, the revision in classifications made and briefly discuss the implications for the clinician and the epidemiologist.
Materials and methods
Compulsory registration of cancer is comparatively recent in Australia. Although the Central Cancer Registry commenced operation in the state of Victoria in 1939 as a hospital based follow-up registry, the statutory collection of all cases of cancer (other than non-melanoma skin cancer) did not start until 1982 (Giles et al., 1985 (Pugh, 1976) Mostofi and Sobin (1977) . Tumours stated to be seminoma without specifying a sub-category were grouped with typical seminoma. Interstitial cell tumours and Sertoli cell tumours were grouped together as tumours of the gonadal stroma. Metastases to the testis and non-malignant conditions were included if they were either the initial diagnosis or the review diagnosis but not both. Some reviews had been done prior to the commencement of this study using alternative classification systems. These diagnostic terms were converted to their equivalents in the British system, with the awareness that the categories do not always completely correspond. This was necessary for 45 (4%) of cases.
All reviews were conducted in the Pathology Department of the PMCI by one of us (PI) or Dr R. Motteram. All cases identified outside PMCI were reviewed during specifically for this study. PMCI usual practice is to review histology of new patients. For 262 (54%) PMCI survey patients it was not considered necessary to conduct another review and that performed at the time of treatment was accepted. The remaining 227 PMCI patients were reviewed at the time of the survey. As a result 184 (38%) of PMCI cases were reviewed twice, with 13 (7%) receiving a major change (seminoma/non-seminoma/non-germ cell) and 29 (15%) a lesser change (sub-groups within a category).
Data analyses were performed on a MicroVax 2 with VMS version 4.7, using purpose written programs. 'Confirmation' is the percentage of tumours assigned initially to a particular category which were confirmed in it upon review. 'Detection' is the percentage of those tumours placed in a category after review which were in it initially. Unknown initial diagnoses were excluded from this calculation.
The 'world standard population' (Doll, 1976) (Stone et al., 1991a) . The definition of testis cancer in these calculations was according to the International Classification of Diseases (World Health Organisation, 1967) , which excludes lymphomas.
Results
In total, 1009 eligible cases were identified, 979 (97%) from orchidectomy specimens, 24 (2%) from biopsies of metastases and seven (1%) from post mortems.
The initial and reviewed classifications of the cases are summarised in Table II Accuracy of diagnosis varied markedly over the time period as shown by the detection and confirmation rates (Table IV ). The overall agreement shows a general trend towards improved accuracy. Overall agreement can be defined as the number of tumours placed in the same major histological category (seminoma/NSGCT/non germ cell) both initially and on review, as a percentage of the total number of tumours assigned specified diagnoses of testicular tumour at both classifications. This was calculated as 82% in 1950-59, 88% in 1960-69 and 93% in 1970-78. In each decade, review reduced the proportion of seminomas in the total series and increased the proportion of NSGCTs and non germ cell tumours (Figure 1 ). Reclassification of diagnoses resulted in changed age specific germ cell = yolk sac tumour, seminoma combined with teratoma or yolk sac tumour. Not testis = metastases to testis, malignancies of other sites and non-malignant conditions. Unkniown = no pathology report, no orchidectomy or no initial site assigned. N/A = not applicable. Detection = percentage of tumours placed in a category after review which were in it initially (denominators exclude unknown initial diagnoses). Confirmation = percentage of tumours assigned initially to a particular category which were confirmed in it upon review. incidences of seminoma and NSGCT, most noticeably in the earliest time period 1950-1959 (Figure 2 ). Trends in age standardised incidence of seminoma and NSGCT were not affected by reclassification although the values were. The trend in age standardised incidence of non germ cell tumours was affected by reclassification ( Figure 3 ). Discussion Teppo (1973) 1950-59 1960-69 1970-78 Figure 3 Effect of review on time trends of age standardised incidence rates of testis cancer, Victoria, Australia 1950 Australia -1978 0---Seminoma before review; seminoma after review; 0---NSGCT before review; 0 0 NSGCT after review; A ---Non germ cell before review; Ai A Non germ cell after review.
cases, ranged from 33% to 71% (Doll et al., 1970) . While some of this variation may be due to differences in the subject populations, it is probable that there would be fewer contradictions and inconsistencies in published reports if the case material were centrally reviewed. NSGCTs showed the reverse pattern to seminomas, with a fairly constant confirmation rate over the time period and an increasing detection rate. This suggests that pathologists became increasingly sensitive to this category during the 1960s. However, the rates for the sub-types were less satisfactory, particularly malignant teratoma intermediate and malignant teratoma trophoblastic. The category of seminoma combined with other elements, while also showing improvement, still had a detection rate of only 53% in the last period, 1970-1978. In the last 15 years, yolk sac tumour has become recognised as a significant component of some adult teratomas (Talerman, 1975) . Among our cases, there were 11 adults ranging in age from 22 to 75 years who appeared, on the sections available, to have pure yolk sac tumours, and four adults with this histology combined with seminoma, age range 29-66. We also found 11 cases of pure yolk sac tumour in children, all under 2 years of age. There is a striking contrast between the accuracy of yolk sac tumour diagnoses, as evidenced by the 100% confirmation rate throughout the time period, and their low detection rate, which showed no improvement with time. This is probably partly due to it not being generally recognised as a distinct category: in the British Testicular Tumour Panel Classification, these were included with malignant teratoma undifferentiated (MTU) (Pugh, 1976) .
In this series, combined tumours were only 8% of germ cell tumours compared to 16% in that of Pugh (1976) (Pugh, 1976) and, unlike teratoma, they are not associated with intra-tubular malignancy (Manivel et al., 1989) .
Epidemiological implications An analysis of the present series based on diagnoses initially provided by pathologists might have suggested that the proportions of seminomas tended to drop and the proportion of NSGCTs and non germ cell tumours tended to rise over the time period. However analysis based on the reviewed series suggests rather that the proportions changed very little, despite the overall increase in incidence (Figure 1) .
The deletions and additions to the seminoma and nonseminoma categories to some extent compensated for each other numerically. However, the age-specific incidences were different after review with the greatest changes occurring in the period [1950] [1951] [1952] [1953] [1954] [1955] [1956] [1957] [1958] [1959] (Figure 2 ). Among seminomas, the incidence was somewhat reduced in the 20-25 age group and age groups over 55, removing the small old age peak. Among NSGCTs, incidence was raised in all age groups over 20. It is likely that the initial and reviewed groups would also differ in characteristics other than age, affecting the outcome of any epidemiological investigations.
Misclassification of non germ cell tumours could also have a discernible effect on analyses of the epidemiology of germ cell malignancies. In particular, under ICD rules (World Health Organization, 1967) , primary lymphomas of the testis should not be grouped with that organ but with the appropriate lymphatic code. Of the 57 testicular lymphomas in the present series, 21 (36%) had been initially diagnosed as seminomas and five (9%) as teratomas (Table II) . The removal of incorrectly assigned lymphomas, which tend to occur at older ages (Abell & Holtz, 1968) , largely accounts for the revised group having a lower incidence of seminomas in age groups over 55 (Figure 2 ).
The well established rising incidence in testicular cancer in Australia and internationally has occurred among germ cell tumours with the incidence of non germ cell tumours generally remaining constant (Stone et al., 1991a; Osterlind, 1986 found associations with seminoma only or NSGCT only (Lipworth & Dayan, 1969; Stone et al., 1991b Clinical implications It is of vital importance to patient management that the pathological opinion on a testicular abnormality be reliable, particularly regarding the existence of malignancy. Of those in our series originally referred as malignant, seven were in fact benign conditions. It is not known how many malignancies erroneously called benign were not referred. In general, the clinical emphasis at PMCI during the period of study was on the broad categories of seminoma and NSGCT, without distinguishing sub-types. In view of the possibility of confusion between anaplastic seminoma and undifferentiated teratoma, most of the former were treated as NSGCTs. As this only meant an increase in the radiation dose to the para-aortic region, their identification had no major clinical impact. Had the policy been to perform routine para-aortic dissection, as was the case in the USA, this might have introduced greater difficulties. Zuckman et al. (1988) contend that mitosis counting is an inexact method of distinguishing between typical and anaplastic seminoma. In their series of 45 seminomas, the anaplastic seminomas displayed no worse behaviour than the typical seminomas. Our own experience suggests that the distinction may not be of clinical importance. From the response to radiation at the lower dose (30 Gray in 4 weeks) there was no difference in the sensitivity of anaplastic seminoma compared to that of typical seminoma, although the former were more aggressive in that the patients presented at a higher stage.
In the 1970s and 1980s effective cytotoxic drugs and sophisticated imaging have revolutionised the management of NSGCTs. The initial choice of strategy depends on accurate classification and staging including the identificaton of vascular invasion by the tumour (Sandeman & Matthews, 1979; Sandeman & Yang, 1985) .
From the clinical point of view, the last decade of this study reveals continuing areas of inadequacy. The detection rate for combined tumours was low, and was due to some being incorrectly assigned to seminoma. The detection rate for lymphomas was also poor. Even where confirmation was high, such as seminoma, there is cause for concern: 9% (21/224) of diagnoses of seminoma were reassigned to NSGCT, lymphoma or gonadal stroma tumours. Incorrect diagnoses such as these potentially result in inadequate or inappropriate therapy. We conclude that the practice at PMCI of routinely reviewing histology was justified in the past and, with the differing modern treatments for seminoma and NSGCT, is even more important today.
Conclusion
The accuracy of classification of testicular tumours by Victorian pathologists has in general improved over the time period studied. This applies both to the broad categories of seminoma, NSGCT and non germ cell tumours, and to the subgroups identified by Pugh. Nonetheless, from the points of view of both epidemiology and patient management, our evidence supports Teppo's (1973) conclusion: primary diagnoses cannot be accepted in epidemiological and clinico-pathological studies which depend on histological sub-groups; central review and reclassification are essential.
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